Cargando…
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
SARS-CoV-2 is a novel coronavirus, spread among humans, and to date, more than 100 million of laboratory-confirmed cases have been reported worldwide. The virus demonstrates 96% similarity to a coronavirus from a horseshoe bat and most probably emerged from a spill over from bats or wild animal(s) t...
Autores principales: | Abdel-Moneim, Ahmed S., Abdelwhab, Elsayed M., Memish, Ziad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898979/ https://www.ncbi.nlm.nih.gov/pubmed/33691216 http://dx.doi.org/10.1016/j.virol.2021.02.007 |
Ejemplares similares
-
Evidence for SARS-CoV-2 Infection of Animal Hosts
por: Abdel-Moneim, Ahmed S., et al.
Publicado: (2020) -
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020) -
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021) -
Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020) -
Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing
por: Aloufi, Bandar Hamad, et al.
Publicado: (2022)